Abstract
AbstractThe streptothricin antibiotics were among the first antibiotics to be discovered from the environment and remain some of the most recovered antimicrobials in natural product screens. Increasing rates of antibiotic resistance and recognition that streptothricin antibiotics may play a role in countering so-called super-bugs has led to the re-evaluation of their clinical potential. Here we will review the current state of knowledge of streptothricins and their resistance in bacteria, with a focus on the potential for new resistance mechanisms and determinants to emerge in the context of potential widespread clinical adoption of this antibiotic class.
Publisher
Springer Science and Business Media LLC
Reference126 articles.
1. O’Neill, J. Tackling drug-resistant infections globally: final report and recommendations. https://wellcomecollection.org/works/thvwsuba (2016).
2. Wright, G. D. Opportunities for natural products in 21st century antibiotic discovery. Nat. Prod. Rep. 34, 694–701 (2017).
3. Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I. & Miller, A. A. ESKAPEing the labyrinth of antibacterial discovery. Nat. Rev. Drug Discov. 14, 529–542 (2015).
4. Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).
5. Talkington, K., Shore, C. & Kothari, P. A Scientific Roadmap for Antibiotic Discovery. https://www.pewtrusts.org/-/media/assets/2016/05/ascientificroadmapforantibioticdiscovery.pdf (2016).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献